[{"NetIncomeLoss_1_Q1_USD":-26535000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":7470000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-25000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":25472000.0,"IncomeTaxesPaid_1_Q1_USD":8000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-9623000.0,"Depreciation_1_Q1_USD":785000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":30221000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":11.61,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1027000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q1_USD":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":26000.0,"AssetsCurrent_0_Q1_USD":267013000.0,"OtherNoncashIncomeExpense_1_Q1_USD":0.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":21265000.0,"ContractWithCustomerLiability_0_Q1_USD":392000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7633000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":1019000.0,"CommonStockSharesIssued_0_Q1_shares":51200000.0,"Assets_0_Q1_USD":305153000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q1_USD":8.65,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":45962000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":7615000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"RevenueFromRelatedParties_1_Q1_USD":1539000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-466000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":20507000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":9.04,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":11800000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-8000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q1_shares":4474000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":49000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":1000.0,"CommonStockValue_0_Q1_USD":51000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":13808000.0,"ShareBasedCompensation_1_Q1_USD":2825000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1_Q1_USD":163000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":91955000.0,"HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q1_USD":37300000.0,"RestrictedCash_0_Q1_USD":1270000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-26543000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-518000.0,"OtherAssetsNoncurrent_0_Q1_USD":3477000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":196273000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":12774000.0,"Liabilities_0_Q1_USD":25699000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":97000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1539000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":14146000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-177536000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":48780000.0,"CommonStockSharesOutstanding_0_Q1_shares":51200000.0,"RestrictedCashNoncurrent_0_Q1_USD":1300000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":1539000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":1000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2825000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-33552000.0,"LiabilitiesCurrent_0_Q1_USD":12925000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q1_USD":18973000.0,"AccountsPayableCurrent_0_Q1_USD":1631000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":197543000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":9535000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":970000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":296000.0,"AdditionalPaidInCapital_0_Q1_USD":456964000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":342000.0,"OperatingLeasePayments_1_Q1_USD":1492000.0,"IncomeLossAttributableToParent_1_Q1_USD":-26534000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":6709000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":7174000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-27000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-139000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":158000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":90985000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":8.24,"CommonStockSharesAuthorized_0_Q1_shares":160000000.0,"OperatingIncomeLoss_1_Q1_USD":-26583000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":61205000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":2800000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":392000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":11.94,"PreferredStockValue_0_Q1_USD":0.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":9559000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":2.98,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2955000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2825000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":15400000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3378000.0,"OperatingExpenses_1_Q1_USD":28122000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-4575000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.58,"OtherLiabilitiesCurrent_0_Q1_USD":54000.0,"StockholdersEquity_0_Q1_USD":279454000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":305153000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":4219000.0,"Ticker":"JNCE","CIK":"1640455","name":"JOUNCE THERAPEUTICS, INC.","OfficialName":"Jounce Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"354419760.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210504"}]